KARKINOX
Live / Applied — Third extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 23 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97604786
- Mark type
- Stylized text
- Filed
- 23 Sept 2022
- Published for opposition
- 02 Apr 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of oncology; pharmaceutical research and development
Owner
- KarkinoX Pharma, Inc., Milpitas, CA, US
- KarkinoX Pharma, Inc., Milpitas, CA, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 3 GRANTED
- 18 Nov 2025 — SOU EXTENSION 3 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 2 GRANTED
- 28 May 2025 — SOU EXTENSION 2 FILED
- 28 May 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2024 — SOU EXTENSION 1 GRANTED
- 28 Oct 2024 — SOU EXTENSION 1 FILED
- 28 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2024 — PUBLISHED FOR OPPOSITION